Taiwan Liposome Company, Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Taiwan Liposome Company, Ltd. - overview
Established
1997
Location
Taipei, -, Taiwan - China
Primary Industry
Pharmaceuticals
About
Founded in 1997 and based in Taipei, Taiwan, Taiwan Liposome Company, Ltd. develops and commercializes nanomedicines for treatment of pain, ophthalmic conditions and infectious diseases.
Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceuticals
Website
www.tlcbio.com
Verticals
Manufacturing
Company Stage
Mature
Total Amount Raised
Subscriber access only
Taiwan Liposome Company, Ltd. - financials
| Fiscal Year Ended | Dec 31, 2011 | Dec 31, 2012 | Dec 31, 2013 | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 78,231,000 | 240,656,000 | 158,644,000 | 95,922,000 | 59,771,000 | 41,674,000 | 49,635,000 | - | - | - |
| % Revenue Growth (YoY) | - | 207.6% | (34.1%) | (39.5%) | (37.7%) | (30.3%) | 19.1% | - | - | - |
| EBITDA (USD) | (202,002,000) | (164,047,000) | (379,556,000) | (620,001,000) | (652,468,000) | (761,459,000) | (845,990,000) | - | - | - |
| Operating Income (USD) | (225,126,000) | (189,779,000) | (409,735,000) | (671,512,000) | (713,398,000) | (836,698,000) | (898,486,000) | - | - | - |
| Operating Margin | (287.8%) | (78.9%) | (258.3%) | (700.1%) | (1193.6%) | (2007.7%) | (1810.2%) | - | - | - |
| % EBITDA Margin | (258.2%) | (68.2%) | (239.3%) | (646.4%) | (1091.6%) | (1827.2%) | (1704.4%) | - | - | - |
| NET Income (USD) | (216,985,000) | (187,128,000) | (400,970,000) | (632,860,000) | (675,685,000) | (824,316,000) | (873,962,000) | - | - | - |
| % Net Margin | (277.4%) | (77.8%) | (252.7%) | (659.8%) | (1130.5%) | (1978.0%) | (1760.8%) | - | - | - |
Taiwan Liposome Company, Ltd. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.